Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Genome-Scale Study ID’s Hundreds of Drug Targets for Huntington’s

03.12.2012
Scientists searching for ways to develop treatments for Huntington’s disease (HD) just got a roadmap that could dramatically speed their discovery process.

Researchers at the Buck Institute have used RNA interference (RNAi) technology to identify hundreds of “druggable” molecular targets linked to the toxicity associated with the devastating, ultimately fatal disease.

The results from this unprecedented genome-scale screen in a human cell model of HD are published in the November 29, 2012 edition of PLoS Genetics. The work was is a collaboration between Buck Institute faculty members Robert E. Hughes, Ph.D., Sean Mooney, Ph.D., Lisa Ellerby, Ph.D. and Juan Botas, Ph.D. at the Baylor College of Medicine.

HD is a devastating and incurable progressive neurodegenerative genetic disorder that affects motor coordination and leads to severe physical and cognitive decline. Currently, there are about 30,000 people in North America diagnosed with HD and another 150,000 people at risk for developing the disease. The disease pathology stems from a mutation in the huntingtin gene (HTT), resulting in the accumulation of a toxic protein leading to neuronal cell death and systemic dysfunction. Buck Scientists screened more than 7,800 genes pre-selected as potential drug targets to identify modifiers of HD toxicity in human cells, using technology that silences specific genes prior to analysis.

Lead author Robert Hughes said that among the diverse range of modifiers identified, this study showed that RRAS, a gene involved in cell motility and neuronal development, is a potent modulator of HD toxicity in multiple HD models. “Our data indicates that the pathogenic effects of the HTT mutation on this pathway can be corrected at multiple intervention points and that pharmacological manipulation of RRAS signaling may confer therapeutic benefit in HD,” Hughes said. Follow up work on the RRAS pathway is now underway in the Hughes lab and in the lab of Buck faculty member Lisa M. Ellerby, PhD.

Hughes said many molecular hits identified in the screening were validated in human cell, mouse cell and fruit fly models of HD – and that all the data from the study will be available to the public. “Our hope is that HD researchers will look at these targets and find modifiers relevant to the areas they already work on,” said Hughes. “Ideally, pharmaceutical companies already working on some these pathways could build on their current knowledge and expertise by focusing their attention on the challenge to develop therapies for HD.”

Citation: “Miller JP, Yates BE, Al-Ramahi I, Berman AE, Sanhueza M, et al. (2012) A Genome-Scale RNA–Interference Screen Identifies RRAS Signaling as a Pathologic Feature of Huntington’s Disease. PLoS Genet 8(11): e1003042. doi:10.1371/journal.pgen.1003042”. Once the paper has been published, it will be accessible at http://www.plosgenetics.org/doi/pgen.1003042.

Contributors to the work:
Buck Institute researchers involved in the work include John Miller, Bridget E. Yates, Ari E. Berman, Francesco DeGiacomo, Cameron Torcassi, Jennifer Holcomb, Juliette Gafni, and Buck faculty members Robert E. Hughes, Lisa M. Ellerby and Sean D. Mooney. Other contributors include Ismael Al-Ramahi, Mario Sanhueza, Eugene Kim, Maria de Haro, and Juan Botas, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX. This work was supported by NIH NS040251, NIH NS055247, CHDI Inc., NIH NS042179, CHDI A-1979, NIH R01 LM009722 and NIH U54-HG004028, NIH T32 training grant AG000266, Hereditary Disease Foundation, John J. Wasmuth Postdoctoral Fellowship and Nathan Shock Center Grant P30AG025708.
About the Buck Institute for Research on Aging
The Buck Institute is the U.S.’s first and foremost independent research organization devoted to Geroscience – focused on the connection between normal aging and chronic disease. Based in Novato, CA, The Buck is dedicated to extending “Healthspan”, the healthy years of human life and does so utilizing a unique interdisciplinary approach involving laboratories studying the mechanisms of aging and those focused on specific diseases. Buck scientists strive to discover new ways of detecting, preventing and treating age-related diseases such as Alzheimer’s and Parkinson’s, cancer, cardiovascular disease, osteoporosis, macular degeneration, diabetes and stroke. In their collaborative research, they are supported by the most recent developments in genomics, proteomics, stem cell technology and bioinformatics. For more information: www.thebuck.org

Kris Rebillot | Newswise Science News
Further information:
http://www.buckinstitute.org

More articles from Life Sciences:

nachricht Family tree for orchids explains their astonishing variability
04.09.2015 | University of Wisconsin-Madison

nachricht Gone with the wind: A new project focusses on atmospheric input of phosphorus into the Baltic Sea
04.09.2015 | Leibniz-Institut für Ostseeforschung Warnemünde

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoperlen für die Stahlschmiede

Stahl gibt es seit rund 3000 Jahren und heute sogar in mehreren Tausend Variationen, und trotzdem ist er immer wieder für Überraschungen gut. Wissenschaftler des Max-Planck-Instituts für Eisenforschung in Düsseldorf haben in einem manganhaltigen Stahl nun beobachtet, dass die Legierung an linienförmigen Defekten eine andere Kristallstruktur bildet, als sie typisch ist für das Material. Sie berichten darüber im Fachjournal Science. Da sich die Länge der Liniendefekte in einem Kubikmeter Stahl auf ein Lichtjahr summieren kann, dürfte die Entdeckung große praktische Bedeutung haben. Denn von der Mikrostruktur eines Stahls hängen auch seine Eigenschaften ab.

Versetzungen können Leben retten. Solche Liniendefekte, genauer gesagt Stufenversetzungen entstehen, wenn eine Atomlage eines Kristalls unvollständig bleibt,...

Im Focus: LARA - Luftgekühlter Radnabenmotor mit hoher Drehmomentdichte auf Basis gegossener Aluminiumspulen

LARA umfasst die Entwicklung, Fertigung und Erprobung eines robusten luftgekühlten Radnabenmotors mit hoher Drehmomentdichte. Dieser kommt als Direktantrieb an allen vier Rädern eines leichten Stadtfahrzeugs als Demonstrator zum Einsatz. Wesentliche Herausforderung ist, das für die Fahrzeugnutzung im urbanen Umfeld notwendige Drehmoment bei hohen Wirkungsgraden aufzubringen und zugleich eine technologisch einfache Luftkühlung zur Abführung der thermischen Verlustleistungen umzusetzen.

Für die Wicklung des Elektromotors werden die vom Fraunhofer IFAM entwickelten gegossenen Spulen mit maximalem Nutfüllgrad eingesetzt, die zur Minimierung von...

Im Focus: Hubble survey unlocks clues to star birth in neighboring galaxy

In a survey of NASA's Hubble Space Telescope images of 2,753 young, blue star clusters in the neighboring Andromeda galaxy (M31), astronomers have found that M31 and our own galaxy have a similar percentage of newborn stars based on mass.

By nailing down what percentage of stars have a particular mass within a cluster, or the Initial Mass Function (IMF), scientists can better interpret the light...

Im Focus: Fraunhofer ISE entwickelt hochkompakten Wechselrichter für unterbrechungsfreie Stromversorgungen

Bauteile aus Siliziumkarbid ermöglichen Wirkungsgrad von 98,7 Prozent

Forscher des Fraunhofer-Instituts für Solare Energiesysteme ISE haben einen hochkompakten und -effizienten Wechselrichter für die unterbrechungsfreie...

Im Focus: Fraunhofer ISE Develops Highly Compact Inverter for Uninterruptible Power Supplies

Silicon Carbide Components Enable Efficiency of 98.7 percent

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE have developed a highly compact and efficient inverter for use in uninterruptible power...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

HMI 4.0 in mobilen Arbeitsmaschinen

04.09.2015 | Veranstaltungen

Innovative Citizen – Festival für neue urbane Fertigkeiten

04.09.2015 | Veranstaltungen

Seilroboter mit Passagier

04.09.2015 | Veranstaltungen

 
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

HMI 4.0 in mobilen Arbeitsmaschinen

04.09.2015 | Veranstaltungsnachrichten

Hinweise auf mikrobielles Leben im Erdmantel unterhalb des Meeresbodens entdeckt

04.09.2015 | Biowissenschaften Chemie

Gleichgewichtsorgan - Flexibler Sensor

04.09.2015 | Biowissenschaften Chemie